首頁 > 市場調查報告書 > 製藥 > 感染疾病 > 瘧疾相關專利動向：2009年

聯絡我們?

市場調查報告書

瘧疾相關專利動向：2009年

Malaria Patent Landscape 2009

出版商	France Innovation Scientifique et Transfert (FIST SA)
出版日期	2009年10月	商品編碼	102159
內容資訊	英文
價格	US $ 1825 PDF by E-mail (Single User License)

簡介
目錄
相關商品

瘧疾相關專利動向：2009年 是由出版商France Innovation Scientifique et Transfert (FIST SA)在2009年10月所出版的。這份英文市場調查報告書價格從美金1825起跳。

簡介

本報告書內容包括：瘧疾相關專利動向分析、個別保護策略、化學療法用化合物、疫苗、診斷藥等領域別專利動向、申請者及發明者動向等。內容綱要摘記如下：

方法

介紹

第1章市場概要

第2章產品線藥概要

第3章保護策略

專利申請
優先申請
擴大發展
產業用專利分析
美國的專利許可
歐洲的專利許可
日本的專利許可
申請人數
IPC編碼

第4章一般分析

該領域的專利拓撲結構
整體投資組合中的主要申請者
主要產業申請者的全球策略矚目焦點
合作
申請者間的引用
最常被引用的專利

第5章化學療法用化合物

一般分析
申請者
發明者

第6章疫苗

一般分析
申請者
發明者

第7章診斷藥品

一般分析
申請者
發明者

第8章其他瘧疾相關專利

申請者
發明者

結論

附錄

申請者別專利數量

開發中企業的專利申請數量

圖表

Malaria, along with HIV and Tuberculosis, is one of the three most common infectious diseases in the world. It has infected human beings for over 50,000 years and may have been a human pathogen throughout the entire history of our species. An estimated 300 million people suffer from this disease and more than one million die each year. Eighty percent of cases are located in Sub-Saharan Africa affecting mainly young children and pregnant women (WHO, 2008). Malaria is a major public health issue commonly associated with poverty, but it is also a cause of poverty and a major hindrance to economic development. Malaria related-illnesses and mortality cost Africa' s economy alone an estimated $12 billion USD per year (Roll Back Malaria).

The cause of malaria was discovered in 1880 by Charles Louis Alphonse Laveran who identified parasites in the red blood cells of people with the disease and suggested that malaria was caused by this protozoan. Malaria is caused by Plasmodium parasites and is transmitted by the female Anopheles mosquito. The most severe form (cerebral malaria) is due to Plasmodium falciparum, the most frequent strain in Africa.

METHODOLOGY

INTRODUCTION

1. BRIEF OUTLINE OF THE MARKET

2. BRIEF OUTLINE OF THE PIPELINE

3. PROTECTION STRATEGIES

3.1. Evolution of patent filings over time
3.2. Priority filings
3.3.Extensions
3.4. Analysis of industrial filings over time
3.5. Study of the granting of US patents
3.6. Study of the granting of European patents
3.7. Study of the granting of Japanese patents
3.8. Evolution in the number of applicants
3.9. Breakdown by IPC codes

4. GENERAL ANALYSIS

4.1. Topology of patents in the sector
4.2. Analysis of the main applicants in the entire portfolio
4.3. Focus on the global strategy of the major industrial applicants
4.4.Collaborations
4.5. Citations between applicants
4.6. Most cited patents

5. FOCUS ON THE CLASSIFIED CHEMOTHERAPEUTIC COMPOUNDS

5.1. General analysis
5.1.1. Breakdown of patent filings over time
5.1.2. Focus on the main chemical classes
5.1.3. Focus on the other chemical classes
5.2.Applicants
5.2.1. Main applicants
5.2.2. Filings by main applicants over time
5.2.3. Topics protected for classified chemotherapeutic compounds
5.2.4. Topics protected for the other classified chemotherapeutic compounds
5.2.5. Emerging applicants
5.3. Inventors
5.3.1. Main inventors
5.3.2. Topics protected for classified chemotherapeutic compounds
5.3.3. Topics protected for other classified chemotherapeutic compounds
5.3.4. Research teams
5.3.5. Experts
5.3.6. Emerging inventors

6. FOCUS ON VACCINES

6.1. General analysis
6.1.1. Patent filings over time
6.1.2. Breakdown of patents by types of vaccines
6.2. Applicants
6.2.1. Main applicants
6.2.2. Topics protected
6.3. Inventors
6.3.1. Main inventors
6.3.2. Topics protected
6.3.3. Research teams
6.3.4. Experts

7. FOCUS ON DIAGNOSTIC

7.1. General analysis
7.1.1. Breakdown of patent filings over time
7.1.2. Breakdown of patents by diagnostic method
7.2. Applicants
7.2.1. Main applicants
7.2.2. Topics protected
7.2.3. Emerging applicants
7.3. Inventors
7.3.1. Main inventors
7.3.2. Topics protected
7.3.3. Research teams
7.3.4. Experts
7.3.5. Emerging inventors

8. FOCUS ON OTHER MALARIA PATENTS

8.1. General analysis
8.1.1. Breakdown of patent filings over time
8.2. Breakdown of other malaria patents
8.3. Applicants
8.3.1. Main applicants
8.3.2. Topics protected
8.4. Inventors
8.4.1. Main inventors
8.4.2. Topics protected

CONCLUSION

APPENDICES

NUMBER OF PATENT FILINGS BY APPLICANTS
NUMBER OF PATENT FILINGS OF COMPANIES PRESENT IN THE PIPELINE

Listo of Figures

FIGURE 1 - NUMBER OF PEOPLE INFECTED BY MALARIA
FIGURE 2 - LIFE CYCLE OF PLASMODIUM PARASITES
FIGURE 3 - TREATMENTS UNDER DEVELOPMENT BY CLASS OF COMPOUNDS
FIGURE 4 - EVOLUTION IN PATENT FILINGS
FIGURE 5 - GEOGRAPHIC DISTRIBUTION OF PRIORITY FILINGS
FIGURE 6 - GEOGRAPHIC DISTRIBUTION OF PRIORITY FILINGS/CLOSE-UP: EUROPE
FIGURE 7 - GEOGRAPHIC DISTRIBUTION OF EXTENSIONS
FIGURE 8 - EVOLUTION OF THE BREAKDOWN OF INDUSTRIAL FILINGS
FIGURE 9 - EVOLUTION OF AVERAGE GRANT TIME FOR US PATENTS
FIGURE 10 - EVOLUTION OF GRANTING OF US PATENTS
FIGURE 11 - EVOLUTION OF GRANTING OF EUROPEAN PATENTS
FIGURE 12 - EVOLUTION OF GRANTING OF EUROPEAN PATENTS
FIGURE 13 - EVOLUTION OF GRANTING OF JAPANESE PATENTS
FIGURE 14 - EVOLUTION OF GRANTING OF JAPANESE PATENTS
FIGURE 15 - EVOLUTION OF THE NUMBER OF APPLICANTS
FIGURE 16 - DISTRIBUTION OF THE 20 MAIN IPC CODES
FIGURE 17 - BREAKDOWN OF THE PORTFOLIO BY APPLICATIONS
FIGURE 18 - MAIN APPLICANTS IN THE ENTIRE PORTFOLIO
FIGURE 19 - BREAKDOWN OF THE MAIN PATENT PORTFOLIO
FIGURE 20 - EXTENSION POLICY FOR THE FIVE MAJOR INDUSTRIAL APPLICANTS
FIGURE 21 - MAJOR COLLABORATIONS AND JOINT FILINGS
FIGURE 22 - MAP OF CITATIONS BETWEEN APPLICANTS
FIGURE 23 - BREAKDOWN OF PATENT FILINGS BY CLASSIFIED CHEMOTHERAPEUTIC COMPOUNDS OVER TIME
FIGURE 24 - BREAKDOWN OF THE PORTFOLIO BY CHEMICAL CLASSES
FIGURE 25 - BREAKDOWN OF THE OTHER CHEMICAL CLASSES
FIGURE 26 - MAIN APPLICANTS OF CLASSIFIED CHEMOTHERAPEUTIC COMPOUNDS
FIGURE 27 - CLASSIFIED CHEMOTHERAPEUTIC COMPOUNDS BY MAIN APPLICANTS
FIGURE 28- OTHER CLASSIFIED CHEMOTHERAPEUTIC COMPOUNDS BY MAIN APPLICANTS
FIGURE 29 - CLASSIFIED CHEMOTHERAPEUTIC COMPOUNDS BY MAIN INVENTORS
FIGURE 30 - OTHER CLASSIFIED CHEMOTHERAPEUTIC COMPOUNDS BY MAIN INVENTORS
FIGURE 31 - CLASSIFIED CHEMOTHERAPEUTIC COMPOUNDS BY MAIN RESEARCH TEAMS
FIGURE 32 - CLASSIFIED CHEMOTHERAPEUTIC COMPOUNDS EXPERTS
FIGURE 33 - BREAKDOWN OF MALARIA VACCINE FILINGS OVER TIME
FIGURE 34 - BREAKDOWN OF THE PORTFOLIO BY TYPES OF VACCINES
FIGURE 35 - MAIN APPLICANTS OF MALARIA VACCINES
FIGURE 36 - MAIN TYPES OF VACCINE BY MAIN APPLICANTS
FIGURE 37 - TYPE OF VACCINES BY MAIN INVENTORS
FIGURE 38 - MAIN MALARIA VACCINE RESEARCH TEAMS
FIGURE 39 - LIST OF EXPERTS DEVELOPING MALARIA VACCINES
FIGURE 40 - BREAKDOWN OF FILINGS ON MALARIAL DIAGNOSTICS OVER TIME
FIGURE 41 - BREAKDOWN OF THE PORTFOLIO BY DIAGNOSTIC METHODS
FIGURE 42 - MAIN APPLICANTS IN MALARIA DIAGNOSTICS
FIGURE 43 - DIAGNOSTIC METHODS OF THE MAIN APPLICANTS
FIGURE 44 - DIAGNOSTIC METHODS DEVELOPED BY THE MAIN INVENTORS
FIGURE 45 - MAJOR COLLABORATIONS BETWEEN INVENTORS IN MALARIA DIAGNOSTICS
FIGURE 46 - LIST OF EXPERTS IN THE FIELD OF MALARIA DIAGNOSTICS
FIGURE 47 - BREAKDOWN OF PATENT FILINGS FOR OTHER MALARIA PATENTS OVER TIME
FIGURE 48 - BREAKDOWN OF OTHER MALARIA PATENTS
FIGURE 49 - MAIN APPLICANTS OF OTHER MALARIA PATENTS
FIGURE 50 - BREAKDOWN OF OTHER MALARIA PATENTS BY MAIN APPLICANTS
FIGURE 51 - OTHER MALARIA PATENTS FILED BY MAIN INVENTORS

List of Tables

TABLE 1 - EVOLUTION OF PRIORITY FILINGS
TABLE 2 - EVOLUTION OF EXTENSIONS
TABLE 3 - DESCRIPTION OF THE 20 MAIN IPC CODES
TABLE 4 - EVOLUTION OF THE 20 MAIN IPC CODES
TABLE 5 - EXTENSION POLICY FOR THE FIVE MAJOR INDUSTRIAL APPLICANTS
TABLE 6 - LIST OF THE MAIN CITED PATENTS PRESENT IN THIS PORTFOLIO
TABLE 7 - LIST OF THE MAIN CITED PATENTS ABSENT OF THIS PORTFOLIO
TABLE 8 - BREAKDOWN BY MAIN CHEMICAL CLASSES OVER TIME
TABLE 9 - BREAKDOWN OF THE OTHER CHEMICAL CLASSES OVER TIME
TABLE 10 - BREAKDOWN OF FILINGS BY MAIN APPLICANTS OVER TIME
TABLE 11 - EMERGING APPLICANTS IN CLASSIFIED CHEMOTHERAPEUTIC COMPOUNDS
TABLE 12 - MAIN INVENTORS OF CLASSIFIED CHEMOTHERAPEUTIC COMPOUNDS
TABLE 13 - EMERGING INVENTORS OF CLASSIFIED CHEMOTHERAPEUTIC COMPOUNDS
TABLE 14 - BREAKDOWN BY TYPE OF VACCINE OVER TIME
TABLE 15 - BREAKDOWN OF MALARIA VACCINE FILINGS BY MAIN APPLICANTS OVER TIME
TABLE 16 - LIST OF MAIN INVENTORS DEVELOPING MALARIA VACCINES
TABLE 17 - BREAKDOWN BY DIAGNOSTIC METHOD OVER TIME
TABLE 18 - BREAKDOWN OF PATENTS FILED BY THE MAIN APPLICANTS IN MALARIA DIAGNOSTICS OVER TIME
TABLE 19 - LIST OF EMERGING APPLICANTS IN THE FIELD OF MALARIA DIAGNOSTICS
TABLE 20 - MAIN INVENTORS IN MALARIA DIAGNOSTICS
TABLE 21 - LIST OF EMERGING INVENTORS IN THE FIELD OF MALARIA DIAGNOSTICS
TABLE 22 - BREAKDOWN OF OTHER MALARIA PATENTS OVER TIME
TABLE 23- BREAKDOWN OF FILINGS OF OTHER MALARIA PATENTS BY MAIN APPLICANTS OVER TIME
TABLE 24 - LIST OF MAIN INVENTORS OF OTHER MALARIA TREATMENTS

簡介
目錄
相關商品

使用指南產品及服務須知網站導覽

星期一到星期五 / 9:30am - 6:00pm
TEL: 02-2729-4219 (+886-2-2729-4219)
E-mail: tw-info@gii.co.jp

瘧疾相關專利動向：2009年

Malaria Patent Landscape 2009

簡介

方法